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Background
UK clinical guidelines recommend treatment of attention-deficit
hyperactivity disorder (ADHD) in adults by suitably qualified
clinical teams. However, young people with ADHD attempting
the transition from children’s to adults’ services experience
considerable difficulties in accessing care.
Aims
To map the mental health services in the UK for adults who have
ADHD and compare the reports of key stakeholders (people with
ADHD and their carers, health workers, service commissioners).
Method
A survey about the existence and extent of service provision for
adults with ADHD was distributed online and via national orga-
nisations (e.g. Royal College of Psychiatrists, the ADHD
Foundation). Freedom of information requests were sent to
commissioners. Descriptive analysis was used to compare
reports from the different stakeholders.
Results
A total of 294 unique services were identified by 2686 respon-
dents. Of these, 44 (15%) were dedicated adult ADHD services
and 99 (34%) were generic adult mental health services. Only 12
dedicated services (27%) provided the full range of treatments
recommended by the National Institute for Health and Care
Excellence. Only half of the dedicated services (55%) and a
minority of other services (7%) were reported by all stakeholder
groups (P < 0.001, Fisher’s exact test).
Conclusions
There is geographical variation in the provision of NHS services
for adults with ADHD across the UK, as well as limited availability
of treatments in the available services. Differences between
stakeholder reports raise questions about equitable access.With
increasing numbers of young people with ADHD graduating from
children’s services, developing evidence-based accessible
models of care for adults with ADHD remains an urgent policy
and commissioning priority.
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The UK National Institute for Health and Care Excellence (NICE)
guidelines state that the following services should be available
for adults with attention-deficit hyperactivity disorder (ADHD):
transitional care, assessment and diagnostic services, medication
titration, monitoring and review, and psychological treatments.1
NICE also recommends that treatment should be holistic and pro-
vided by multidisciplinary teams or clinicians with expertise in
ADHD, with shared care protocols with primary care in place
after medication titration and dose stabilisation.1 Shared care is
defined as the planned joint participation of consultants and
general practitioners (GPs) in the delivery of care for patients
with a chronic condition.2 Although there are effective, evidence-
based treatments for adults who have ADHD,3 there is no consensus
about the optimum organisation of health services to provide them.4
Mounting evidence suggests that, despite evidence-based treat-
ments, guideline recommendations are frequently ignored, so that
adults with ADHD struggle to access appropriate healthcare.5
A recent systematic review found that a lack of available informa-
tion about services for adults with ADHD created difficulties for
both referring clinicians and patients accessing treatment.6 People
with ADHD are already at increased risk of poor health, social, edu-
cational and occupational outcomes, and without access to appro-
priate healthcare they face higher risks of negative outcomes,
including substance misuse, criminality and road traffic acci-
dents.5,7–9 As increasing numbers of young people with ADHD
graduate from children’s services, providing national information
about adult services and investigating access to care are priorities.
At the time we undertook this study (January–February 2018),
there was limited research and grey literature about the provision of
services for adults with ADHD across the UK. Studies reported in
the literature either covered a specific region or described young
people’s experiences of transition, rather than mapping the services
available for young people with ADHD transitioning to mental
health services for adults.10–14 In addition, studies of service avail-
ability have tended to draw on the perspectives of one type of stake-
holder, such as senior healthcare professionals (not working in
frontline services)14 or healthcare professionals working in child
or adult health services,10 rather than including perspectives of
senior healthcare staff, frontline staff, commissioners and patients.
Surveying a range of key stakeholders minimises the likelihood
that a service will be overlooked, while comparison of their
reports provides important information about gaps in awareness
among different groups.
As recommended by Hall et al in 2013, the study reported in this
paper aimed to provide national-level data on UK mental health
service provision for adults with ADHD.10 We aimed to provide:
a geographical overview of services; details of treatment provided
by dedicated National Health Service (NHS) adult ADHD services;
and an exploration of differences in reports of services by key stake-
holder group (commissioners, health workers and service users).
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Method
This work formed part of the Children and Adolescents with ADHD
in Transition from Child to Adult Services (CATCh-uS) study of
transition in ADHD.15 We assert that all procedures contributing
to this work comply with the ethical standards of the relevant
national and institutional committees on human experimentation
and with the Helsinki Declaration of 1975, as revised in 2008. All
procedures involving human participants were approved by the
University of Exeter Medical School Ethics Committee (research
ethics committee application number: 15/07/070). Following con-
sultation with the research ethics committee, a statement on
confidentiality and data usage was included at the beginning of
the survey, with the understanding that, by continuing with the
survey, participants were providing informed consent for the
planned anonymous use of their data.
The novel mapping methodology was developed iteratively,
with extensive patient and public involvement and is reported in
full elsewhere.16 The definitive study is described below.
Participants
Our sample frame was all stakeholders involved in the care process
for young people needing transition from child to adult services, as
well as those involved in allocating and financing local services. This
included young adults with ADHD and their parents/carers,
members of clinical teams (such as psychiatrists, paediatricians,
psychologists, GPs, nurses, practice managers, administrators)
and service commissioners (clinical commissioning groups in
England, health boards in Scotland and Wales, and health and
social care trusts in Northern Ireland).
Sampling strategy
Informants were purposively sampled from three key stakeholder
groups (service users, healthcare workers and commissioners) via
multiple methods. Three data sources informed the service map: a
national online survey, freedom of information (FOI) requests
and a surveillance study.
Anonymous national online survey (convenience sample)
Links to an online survey were shared with stakeholders via emails
from organisational mailing lists, newsletters and websites, and
through social media. A snowballing technique was used to
recruit additional stakeholders and their organisations. The survey
was open for 5 weeks from January 2018.
Freedom of information requests (total population)
Organisations responsible for commissioning, or planning and
funding, NHS mental health services in the UK were sent survey
questions via FOI requests in January 2018. These are legal pro-
cesses that support the rights of people to gain access to information
that is recorded and held by public-sector organisations.17 A copy of
the survey, examples of FOI requests made and a list of key support-
ing organisations are provided in the supplementary material, avail-
able at https://doi.org/10.1192/bjo.2020.65.
Surveillance (purposive sample)
Reports of transition in ADHD services were collated from paedia-
tricians and psychiatrists who responded to a national surveillance
study on young people in need of a transition into adult services.
This was run via the British Paediatric Surveillance Unit and the
Child and Adolescent Psychiatry Surveillance System from
December 2016 for 12 months. Reported cases were followed up
after 9 months (August 2017 to August 2018).
Data collection
Survey
The brief online survey, hosted by Survey Monkey, consisted of
between five and nine questions, depending on user responses. It
collected basic demographic information, including respondents’
locations (postcode or region in the UK) and respondents’ links
with ADHD (e.g. ‘adult with ADHD’ or ‘psychiatrist’), then asked
for details of services they had knowledge of for adults with
ADHD. Services were broadly defined as ‘any mental health
service for people with ADHD aged 18 and above’, with notes clari-
fying that this could include any ‘specialist doctor or team, mental
health team, clinic, charity or support group that treats or supports
adults with ADHD’. Respondents identified services from a pre-
populated list and could identify services that were not already
listed. For every service they identified, respondents were asked to
confirm whether it was somewhere that they, or someone they
knew of, had ‘received treatment or support […] for their adult
ADHD’.
FOI requests collected basic demographic information on the
commissioning organisation and asked whether they commissioned
‘mental health services that treat/support people with ADHD aged
18 years and above’. If yes, they were asked to provide details of the
services that were similar to the details requested in the survey, as
well as to specify the type of service and which treatments were
available.
For all NHS-provided dedicated adult ADHD services (group A;
see definition below), details of provision were also checked via FOI
requests to the provider (details in the supplementary material).
Surveillance study
TheCATCh-uS national surveillance study collected data from child
and adolescent psychiatrists and paediatricians on transition out-
comes of young adults with ADHD.18 Reports of services from this
study were triangulated with services already mapped, with the
intention of incorporating additional services, if any were reported.
Data analysis
Sample
Informants were categorised into three main stakeholder groups
(service user, commissioner or health worker), depending on their
strongest link with ADHD. For example, a parent/carer/partner of
someone with ADHD was categorised as a service user, while psy-
chiatrists were categorised as health workers. Descriptive statistics
summarised respondents’ characteristics by data source, geographic
location and stakeholder group (service user, commissioner or
health worker). Given the non-probabilistic sampling frame, a prag-
matic minimum target of 50 informants per UK NHS region was
identified to ensure adequate coverage.
Data cleaning
Raw data on services were matched against existing online informa-
tion by A.P. and checked at least once by other members of the
research team. Where details could not be matched to an existing
service, they were independently checked a minimum of three
times before being categorised as unidentifiable.
Services identified
All of the identified services were recorded. Services for which at
least one respondent had confirmed experience of treatment for
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their ADHD as an adult were categorised into the following three
groups:
(a) NHS dedicated services for adults with ADHD
(b) NHS non-dedicated services for adults with ADHD
(c) other services that work with adults with ADHD (including
NHS provision for children, charity/voluntary and private).
Services were defined as dedicated if they had ‘ADHD’ or ‘neu-
rodevelopmental’ in the service name. The term ‘dedicated’ was
used rather than ‘specialist’ so that generic NHS services with
named clinics with dedicated time for adults with ADHD would
be included. Service locations were plotted on a map of the UK,
using QGIS 2.18 for Windows19 and uploaded onto a Google My
Map to provide a visual summary of service availability and to com-
municate findings with stakeholders. The balance of responses by
UK region and stakeholder group was similarly mapped.
Stakeholder perspectives
For each service, a descriptive summary was created of the stake-
holder groups, and combinations of stakeholder groups, that had
identified that service. The percentages of services identified by
stakeholder group, and for each service type, were summarised and
tabulated. The association between stakeholder type and service
reportingwas tested using Pearson’s χ2. Differences between combina-
tions of stakeholders reporting services were tested using Fisher’s exact
test, and overlap was displayed using Venn diagrams.
Results
Informants
In total, 2686 reports of services were included in the study: 73%
(n = 1946) were from health workers, 17% (n = 461) from service
users, 8% (n = 216) from commissioners and 2% (n = 63) from
others such as educational practitioners or researchers.
Most reports of services (n = 2158, 80%) were obtained from the
online survey, compared with commissioners responding to FOI
requests (n = 213, 8%) and the surveillance study (n = 315, 12%).
Of the 236 organisations sent FOI requests, 213 (90%) responded.
Response rates to questionnaires for the surveillance study were
also high (79% at baseline, 82% at follow-up). The minimum of
50 informants per NHS region report was reached for every
region except Wales, where 40 reports were received. For a
geographic overview of the locations of informants, see Fig. 1.
A more detailed breakdown of the sample by data source and stake-
holder identity is available in the CATCh-uS study report.20
NHS dedicated services for adults with ADHD Number of
informants
50–200
200–350
35–500
500 +
<50
Fig. 1 Numbers of mapping study informants per National Health Service (NHS) region, and the locations of the 44 NHS dedicated services for
adults with attention-deficit hyperactivity disorder (ADHD) in the UK (group A), as identified by study informants.
Mapping UK services for adults with ADHD
3
Downloaded from https://www.cambridge.org/core. 24 Nov 2020 at 09:44:41, subject to the Cambridge Core terms of use.
Services
In total, 294 unique services were identified, with 254 services for
which informants confirmed experience of treatment or support
for an adult with ADHD (Table 1.)
Dedicated services
Responses to FOI requests checking details of provision at the 44
NHS dedicated services for adults with ADHD (group A) were
received from 89% (31/35) of providing organisations. Responses
indicated that only 12 services (27%) offered the range of interven-
tions specified by NICE.1 Services were most likely to offer medica-
tion management, shared care or ongoing prescribing (n = 39, 89%)
and diagnostic assessment (n = 36, 82%); psychological treatment
(n = 22, 50%) and transitional care (n = 26, 59%) were less fre-
quently reported. Two services (5%) reported an upper age limit
of 65 years, and almost one-third (n = 13, 30%) reported that
patients from outside their commissioned area might be able to
access treatments in that service. Figure 1 illustrates the uneven dis-
tribution of NHS dedicated services for adults with ADHD across
the UK.
Stakeholder perspectives
Table 2 provides a descriptive summary of service reporting by
stakeholder group and combination of stakeholder groups, and
Fig. 2 indicates the overlap, or lack thereof, between their reports
of different levels of service provision.
There were significant differences in the proportions of NHS
dedicated adult (group A), NHS non-dedicated adult (group B)
and other (group C) services reported by each stakeholder group
(χ2(4,399) = 34.29, P < 0.001). Service users were marginally more
likely to report group A or group C services, and less likely to
report group B services (χ2(2,344) = 7.13, P = 0.03). Health
workers reported similar proportions of group A, B and C services
(χ2(2,471) = 0.26, P = 0.88). Commissioners were more likely
to report group A services than group B or C (χ2(4,399) = 34.29,
P < 0.001).
As Fig. 2 illustrates, a higher proportion of NHS dedicated adult
(group A) services was reported by all stakeholder groups (n = 24,
55%), compared with NHS non-dedicated adult (group B) services
(n = 7, 7%) and other (group C) services (n = 7, 6%; P < 0.001,
Fisher’s exact test). The majority of NHS non-dedicated adult
(group B) and other (group C) services were reported by health
workers alone.
Discussion
The study reported in this paper makes a unique contribution to the
research literature by presenting national-level data about the ser-
vices for adults who have ADHD that were available in the UK in
2018. It highlights geographical gaps in NHS services in the UK
for adults who have ADHD, shows that service provision is
limited, and documents major differences in different groups of sta-
keholders’ awareness of the services that are available. In doing so, it
updates, supports and extends the existing evidence of patchy pro-
vision.10,11,13,14 The significant differences in the types of services
identified by stakeholders raise questions about equitable access to
care for adults with ADHD, particularly in areas without dedicated
services.
Service types
Gaining a clear picture of provision was not straightforward because
of differences in NHS service organisation by country and region of
the UK. For example, many health services in England are funded
via commissioning bodies, whereas in other countries, such as
Wales, the commissioning process is often described instead as
planning and financing, with the agencies responsible the same as
those responsible for service delivery. Differences in the structures
of the respective National Health Services of each country in the
UK, and how they function across the four jurisdictions, may
have influenced the number of responses we had, as well as the
way that services were reported.
Informants reported experiences of treatment for adults with
ADHD at a range of service types. However, only 44 were ‘dedi-
cated’ NHS services for adults (those with ‘ADHD’ or ‘neurodeve-
lopmental’ in their name) and, of these, less than one-third
offered the full range of treatments recommended by the NICE
guidelines.1 Although treatment with medication was available at
more than 80% of dedicated services, psychological treatment was
available at only half. It is possible that the treatments recom-
mended by NICE that were not available at some dedicated services
were provided by other local NHS services. This seems to us to be
unlikely, given that previous research suggests that patients struggle
Table 1 Services for adults with attention-deficit hyperactivity disorder (ADHD) by service group and service type
Services for adults with ADHD, by service group Service type Service types, n Total by service group, n (%)
Group A: NHS dedicated services for adults NHS adult ADHD 29
NHS adult ADHD and ASD 7
NHS adult neurodevelopmental 8 44 (17)
Group B: NHS non-dedicated services for adults NHS 0–25 year-olds 2
NHS adult ASD 2
NHS adult drug and alcohol 1
NHS AMH CMHT 70
NHS health and social care 1
NHS adult learning disability 17
NHS AMH and learning disability 2
NHS AMH primary care 2
NHS AMH prison and custody 2 99 (39)
Group C: Other services for adults with ADHD Charity/Voluntary 15
Charity/Voluntary (support group) 24
NHS child ADHD specialist 3
NHS child neurodevelopmental 3
NHS generic child 26
Private 36
Private (social enterprise) 4 111 (44)
NHS, National Health Service; ASD, autism spectrum disorder; AMH, adult mental health; CMHT, community mental health team; learning disability, the NHS term for intellectual disability;
child, child and adolescent mental health or paediatric service (for under 18-year-olds).
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to access the full range of recommended services, including support
for young people who are transitioning between services, and psy-
chological treatments.6,18,21 Dedicated services did not indicate to
us that they sourced these treatments for patients elsewhere, but
further research could explore this explicitly.
Owing to the current complexity of the organisation of services
for adults with ADHD in the UK, it was difficult to assess whether a
lack of a dedicated service equated to the lack of any commissioned
service for adults with ADHD in that area. Existing evidence sug-
gests that young people with ADHD may not meet referral criteria
for generic adult mental health services, and there can be difficulties
in accessing treatment related to a lack of training and specialist
knowledge among staff.4,6 Some stakeholders would argue that
UK regions with no ‘dedicated’ services represent a gap in provision
of care for adults with ADHD. Although an additional 99 ‘non-dedi-
cated’ UK adult NHS services were identified, their existence was
most commonly reported only by health workers, rather than
service users or commissioners. This suggests that these services
may be less accessible, with possible implications for resourcing.
Existing qualitative research suggests that service users may be
more satisfied with the care for adults who have ADHD that they
received at dedicated or ‘specialist’ services.22
A surprisingly high number of ‘other services’ were identified at
which support had been experienced, including child NHS services,
private and charitable services. These may represent additional
choice and a richer variety of healthcare options, although this
needs consideration in the context of difficulties faced by patients
trying to access appropriate NHS care for adult ADHD.23
Previous research suggests that clinicians who work in NHS-pro-
vided services for children may continue to deliver treatment
beyond the upper age specified for their service in locations where
no service for adults is available. This may have an impact on the
capacity to respond to younger children in need.21 There are also
reports of adults seeking privately funded healthcare when no
other route to treatment is available,24 and 40 such services were
reported in the present study, highlighting potentially significant
out-of-pocket expenses incurred by people with ADHD. This
raises concerns for the well-being of the most vulnerable members
of the population for whom private healthcare is not an option
and who lack advocates to negotiate or navigate services on their
behalf.
There is still no clear consensus on optimal models for the pro-
vision of care for adults with ADHD;4 the NICE guidelines state
only that a service should be provided by teams of ‘healthcare pro-
fessionals with training and expertise in diagnosing and managing
ADHD’.1 Future research should explore different models of
service provision within primary and secondary healthcare services,
including evaluations of their effectiveness and cost-effectiveness.
There is also scope for further mapping to explore the uptake and
availability of shared care for ADHD, as qualitative research sug-
gests that some young adults are treated exclusively by their GPs,
while others experience difficulties finding a GP willing to prescribe
medication even under shared care arrangements.20 This suggests
that the implementation of shared care arrangements may be
highly variable.
Strengths and limitations
This research has provided the most extensive data to date about the
availability of services for adults in the UK who have ADHD, and it
extends existing region-specific and single-source information10,14
by triangulating reports from a range of stakeholders. The use of
FOI requests to contact commissioners ensured that staff with
time and resources responded to enquiries, and proved effective,
with a 90% response rate. The novel survey methodology, including
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collaboration with partner organisations, was a rapid and effective
way of gathering reports from a range of stakeholders across the
UK.16 However, although a target minimum number of responses
was received from all but one UK region, the use of non-probabil-
istic sampling methods meant that respondents were not selected
randomly. Necessarily, informants would have been computer liter-
ate and interested in ADHD. It is possible that this introduced bias,
with survey informants more likely to be those who had struggled to
access healthcare. The use of multiple informants and methods,
combined with the high number of responses, mitigated the risk
of bias and made it likely that the vast majority of relevant services
were identified.
A clearer definition of ‘dedicated’ services would have improved
the quality of the service map. However, given the complexity of
health service provision in the UK, which made it difficult to be
sure that health workers, service users and commissioners were
identifying the same unit of ‘service’ when responding to the
survey, we chose our definition to ensure that specialist teams and
those generic services with practitioners with dedicated time to
focus on adults with ADHD could be included on the map. The
methodological decision to label services as dedicated meant that
identified services comprised a range, from highly specialist national
and regional services to clinicians with only a few days a month
dedicated to ADHD-related work within their generic adult
mental health service. Resource limitations meant that service
details were checked only with providers of dedicated services,
and their capacity, in terms of staffing levels, and key indicators
such as waiting-list times were not evaluated. During analysis, dif-
ferences in service organisation by country and region of the UK
made it difficult to ascertain whether an area without a dedicated
service was also therefore an area without a commissioned service
for adults with ADHD. Findings from the analysis of differences in
reporting should be considered in the context of the balance of
survey responses, with the majority of responses coming from
health workers. As UK health services for adults with ADHD
are continually evolving, this research provides only a snapshot
in time. However, this baseline map of services has been hosted
by the UK Adult ADHD Network (https://www.ukaan.org/adult-
adhd-service-map), which will maintain and update it over time,
so that it is a useful resource for all stakeholders.
Implications
Given the importance of continuing treatment for ADHD into
adulthood where needed,5,7,8 the increasing numbers of young
people with ADHD graduating from child services and the existence
of effective evidence-based treatments,3 these data highlight the
urgent need to improve provision and access for this vulnerable
population. Clearly defined, accessible and equitable services for
adults with ADHD are needed, combined with better information
about what is available for public and professionals. The map of ser-
vices is a tangible resource to provide better quality and accessible
information to all stakeholders, the lack of which has been identified
as a barrier when patients need to transition into adult services.6
The geographic gaps in the availability of NHS dedicated ser-
vices for adults with ADHD, as well as limited availability of the
treatment options recommended in the NICE guidelines, suggests
that where someone lives will have an impact on whether or not
appropriate treatment is available to them, which is contrary to
the stated aim of the NHS of equitable access to appropriate health-
care for people with long-term conditions, and should be addressed
as a matter of urgency.
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Fig. 2 Venn diagrams illustrating the combinations of stakeholder groups identifying services for adults with attention-deficit hyperactivity
disorder. The service user group includes both adults with ADHD and parents/carers/partners of someone with ADHD.
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